| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
138,223
|
152,162
|
141,621
|
117,978
| | Cost of Revenue | 43,341 | 49,547 | 49,961 | 51,565 | | |
Gross Profit
|
94,882
|
102,615
|
91,660
|
66,413
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 17,984 | 12,278 | 23,063 | 26,972 |
|
Non Recurring | 10,707 | 324,040 | 318,044 | 428,801 |
|
Others | 41,998 | 56,639 | 71,574 | 88,301 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
209,075
|
(307,371)
|
(321,021)
|
(476,036)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 141,456 | 31,138 | (20,112) | (13,436) |
|
Earnings Before Interest And Taxes | 178,312 | (250,605) | (328,239) | (476,064) |
|
Interest Expense | 20,192 | 18,424 | 17,935 | 20,369 |
|
Income Before Tax | 158,120 | (269,029) | (346,174) | (496,433) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 170,783 | (260,430) | (333,280) | (481,400) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
158,120
|
(269,029)
|
(346,174)
|
(496,433)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
158,120
|
(269,029)
|
(346,174)
|
(496,433)
|
|